Related Experiment Videos

Interferon-mediated protection of B16 melanoma cells from cytotoxicity by activated macrophages

Cellular Immunology
|June 1, 1986
PubMed

Insights

Interferons (IFN) protect B16 melanoma cells from macrophage-mediated cytotoxicity. This protective effect was dose-dependent, with IFN-gamma showing greater efficacy than IFN-alpha/beta, indicating IFNs can alter tumor cell susceptibility to immune attack.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Cytotoxicity

Background:

  • Activated macrophages (M phi) exhibit cytotoxic activity against tumor cells.
  • Tumor cells can modulate their susceptibility to immune-mediated killing.

Purpose of the Study:

  • To investigate the effect of interferon (IFN) pretreatment on the susceptibility of B16 melanoma cells to macrophage-mediated cytotoxicity.
  • To compare the protective efficacy of different types of IFNs.

Main Methods:

  • B16 melanoma cells were pretreated with various concentrations of interferon-alpha/beta or interferon-gamma.
  • Cytotoxicity was assessed by co-culturing treated melanoma cells with Corynebacterium parvum-activated macrophages.
  • Monoclonal antibodies against IFN-gamma were used to neutralize its protective effect.

Main Results:

  • Interferon pretreatment significantly reduced the susceptibility of B16 melanoma cells to macrophage-mediated killing.
  • The protective effect of IFNs was dose-dependent.
  • Interferon-gamma demonstrated a greater protective effect compared to interferon-alpha/beta.
  • Neutralization with anti-IFN-gamma antibodies abolished the protective effect of IFN-gamma.

Conclusions:

  • Interferon pretreatment can alter tumor cell susceptibility to activated macrophage cytotoxicity.
  • IFN-gamma is a potent modulator of tumor cell resistance to immune attack.
  • These findings highlight the potential of IFNs in modulating anti-tumor immune responses.

Related Concept Videos